España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Aligos Therapeutics
ALGS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Aligos Therapeutics (ALGS) Forecast
News
Earnings
Aligos Therapeutics (ALGS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Aligos Therapeutics (NASDAQ:ALGS) Stock
Aligos Therapeutics Stock (NASDAQ: ALGS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
Aligos Therapeutics Shares Resume Trade
Benzinga Newsdesk
Aligos Therapeutics Shares Halted On Circuit ...
Benzinga Newsdesk
Aligos Therapeutics Presents Data From One La...
Benzinga Newsdesk
Monday, November 11, 2024
Aligos Therapeutics Shares Resume Trade
Benzinga Newsdesk
Aligos Therapeutics Shares Halted On Circuit ...
Benzinga Newsdesk
Aligos Therapeutics Shares Resume Trade Follo...
Benzinga Newsdesk
Thursday, November 07, 2024
Aligos Therapeutics shares are trading higher...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Aligos ...
Benzinga Newsdesk
Wednesday, November 06, 2024
Aligos Therapeutics Q3 2024 GAAP EPS $(3.07) ...
Benzinga Newsdesk
Wednesday, October 23, 2024
HC Wainwright & Co. Reiterates Buy on Aligos ...
Benzinga Newsdesk
Tuesday, October 22, 2024
Aligos Therapeutics Announces U.S. FDA Cleara...
Benzinga Newsdesk
Tuesday, October 15, 2024
Aligos Therapeutics Abstracts On Incremental ...
Benzinga Newsdesk
Friday, September 20, 2024
HC Wainwright & Co. Reiterates Buy on Aligos ...
Benzinga Newsdesk
Thursday, September 19, 2024
Aligos Therapeutics shares are trading lower....
Benzinga Newsdesk
Aligos Therapeutics Announces Results From Ph...
Benzinga Newsdesk
Wednesday, September 18, 2024
Aligos Therapeutics Plans To Share Topline Re...
Benzinga Newsdesk
Monday, August 19, 2024
Aligos Therapeutics shares are trading higher...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On Ali...
Benzinga Newsdesk
Friday, August 16, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Thursday, August 15, 2024
Aligos Therapeutics Announces 1-for-25 Revers...
Benzinga Newsdesk
Wednesday, August 07, 2024
Aligos Therapeutics shares are trading higher...
Benzinga Newsdesk
Tuesday, August 06, 2024
Aligos Therapeutics Q2 2024 GAAP EPS $0.03 Be...
Benzinga Newsdesk
Monday, July 22, 2024
Aligos Therapeutics And Amoytop To Sponsor Ph...
Benzinga Newsdesk
Wednesday, July 10, 2024
Aligos Therapeutics To Host Key Opinion Leade...
Benzinga Newsdesk
Thursday, June 27, 2024
Beam Therapeutics Begins Dosing in Phase I/II AATD Study
Zacks
Wednesday, June 05, 2024
Aligos Therapeutics Presented Poster Highligh...
Benzinga Newsdesk
Friday, May 31, 2024
Aligos Therapeutics Receives Nasdaq Notice Of...
Benzinga Newsdesk
Tuesday, May 21, 2024
Aligos Therapeutics Completes Enrollment In T...
Benzinga Newsdesk
Tuesday, May 07, 2024
Aligos Therapeutics Q1 2024 GAAP EPS $(0.22) ...
Benzinga Newsdesk
Thursday, April 25, 2024
Aligos Therapeutics Presents Clinical Data At...
Benzinga Newsdesk
Wednesday, April 03, 2024
Aligos Therapeutics Announces First Subjects ...
Benzinga Newsdesk
Monday, April 01, 2024
Earlier Announced, Aligos Therapeutics Has Be...
Benzinga Newsdesk
Wednesday, March 27, 2024
Aligos Therapeutics Presents Clinical Data At APASL 2024 From ALG-055009 And ALG-000184 Phase 1 Studies
Happy Mohamed
Monday, March 18, 2024
Aligos Therapeutics Announces Initiation Of P...
Benzinga Newsdesk
Friday, March 15, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, March 12, 2024
Recap: Aligos Therapeutics Q4 Earnings
Benzinga Insights
Aligos Therapeutics Q4 2023 GAAP EPS $(0.22) ...
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
Aligos Therapeutics Earnings Preview
Benzinga Insights
Tuesday, February 20, 2024
Aligos Therapeutics To Host KOL Event To Disc...
Benzinga Newsdesk
Friday, December 08, 2023
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, December 07, 2023
Aligos Therapeutics shares are trading higher...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Aligos Therapeutics Presents Clinical Data At...
Benzinga Newsdesk
Monday, November 20, 2023
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
Lisa Levin
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, November 17, 2023
Aligos Therapeutics Inc Files Prospectus Rela...
Benzinga Newsdesk
Monday, November 13, 2023
Aligos Therapeutics Presents Clinical And Non...
Benzinga Newsdesk
Friday, November 10, 2023
Aligos Therapeutics Presents Data At The AASL...
Benzinga Newsdesk
Tuesday, November 07, 2023
Aligos Therapeutics To Present Multiple Poste...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
